Zydus Cadila Launches a Research Program to Develop Vaccine Against Coronavirus
Shots:
- Zydus has initiated an accelerated research program with multiple teams in India and the EU to develop a vaccine against coronavirus- 2019-nCoV (COVID-19) based on two approaches
- The two approaches include the development of DNA vaccine by Zydus’ VTC and a live attenuated recombinant measles virus vectored vaccine by Zydus’ Etna Biotech to combat COVID
- Zydus’ manufacturing facilities for producing recombinant antigens and measles-containing vaccines will enable rapid ramping up of the production for both vaccine candidates- once the proof-of-concept is established
Click here to read full press release/ article | Ref: Zydus Cadila | Image: Zydus Cadila
This content piece was prepared by our former Senior Editor. She had expertise in life science research and was an avid reader. For any query reach out to us at connect@pharmashots.com